BioCentury
ARTICLE | Clinical News

Alimta pemetrexed regulatory update

September 28, 2009 7:00 AM UTC

The U.K.'s NICE issued guidance recommending the use of Alimta pemetrexed from Eli Lilly for first-line treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC) in combination wi...